InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: greene2 post# 71564

Saturday, 06/16/2018 2:58:55 PM

Saturday, June 16, 2018 2:58:55 PM

Post# of 108192
If I go by the time-frame of the clinical trials website, the PI has an estimated start date of March 2018, a primary completion date of Sept. 2019 and a study completion date of Sept. 2020. So, 2.5 years to POC may be a bit optimistic, depending on how enrollment goes and how long the PII would run. In an ideal world Amgen would step-up and just buy us long before then. Hovacre could shed more clarity on the question.

https://clinicaltrials.gov/ct2/show/NCT03265080?term=advaxis&draw=3&rank=1
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News